Evidence map›Paper›PMID 37406039›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Maternal Colonization Versus Nosocomial Transmission as the Source of Drug-Resistant Bloodstream Infection in an Indian Neonatal Intensive Care Unit: A Prospective Cohort Study.

Matthew L Robinson, Julia Johnson, Shilpa Naik, Sunil Patil, Rajesh Kulkarni, Aarti Kinikar, Vaishali Dohe, Swati Mudshingkar, Anju Kagal, Rachel M Smith and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Intensive Care Unit-onset Bloodstream Infections Represent a Distinct Category of Hospital-onset Infections: A Multicentre, Retrospective Cohort Study. Queensland Critical Care Network (QCCRN).Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2024
    Article
  11. Article
  12. Review
  13. Antibiotic Resistance: A Global Problem and the Need to Do More.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 2 countries.

Matthew L RobinsonDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-0376-8560
Julia JohnsonDivision of Neonatology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Shilpa NaikDepartment of Obstetrics, Byramjee Jeejeebhoy Government Medical College, Pune, India.
Sunil PatilDepartment of Obstetrics, Byramjee Jeejeebhoy Government Medical College, Pune, India.
Rajesh KulkarniDepartment of Pediatrics, Byramjee Jeejeebhoy Government Medical College, Pune, India.
Aarti KinikarDepartment of Pediatrics, Byramjee Jeejeebhoy Government Medical College, Pune, India.
Vaishali DoheDepartment of Microbiology, Byramjee Jeejeebhoy Government Medical College, Pune, India.
Swati MudshingkarDepartment of Microbiology, Byramjee Jeejeebhoy Government Medical College, Pune, India.
Anju KagalDepartment of Microbiology, Byramjee Jeejeebhoy Government Medical College, Pune, India.
Rachel M SmithCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Matthew WestercampCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Bharat RandiveByramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, India.
Abhay KadamByramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, India.
Ahmed BabikerDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Vandana KulkarniByramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, India.
Rajesh KaryakarteDepartment of Microbiology, Byramjee Jeejeebhoy Government Medical College, Pune, India.
Vidya MaveDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Amita GuptaDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Aaron M MilstoneDivision of Pediatric Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Yukari C ManabeDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Johns Hopkins University · USGovernment Medical College · INCenters for Disease Control and Prevention · USEmory University · US

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the USUM1AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI Sharon A Nachman · 2011 to 2026
$278.1M
Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU)UM1AI069465 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Charles W. Flexner, Amita Gupta · 2012 to 2026
$34.1M
INTERFACE OF BORRELIA SURFACE PROTEINS AND ANTIBODIESR01AI037248 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI BARBOUR, ALAN G. · 1994 to 2004
$1.5M
Mentoring in prevention of hospital-acquired infections and antibiotic resistanceK24AI141580 · NIAID · JOHNS HOPKINS UNIVERSITY · PI AARON M MILSTONE · 2019 to 2026
$1.4M
Preventing antimicrobial resistance and infections in hospitalized neonates in low resource settingsK23HD100594 · NICHD · JOHNS HOPKINS UNIVERSITY · PI JOHNSON, JULIA · 2020 to 2024
$857k
NIAID NIH HHS K24 AI141580NIAID NIH HHS R01 AI037248NIAID NIH HHS UM1 AI068632NIAID NIH HHS UM1 AI068636NIAID NIH HHS UM1 AI069465NIAID NIH HHS UM1 AI104681NICHD NIH HHS K23 HD100594
6 · The paper itself

Abstract

backgroundDrug-resistant gram-negative (GN) pathogens are a common cause of neonatal sepsis in low- and middle-income countries. Identifying GN transmission patterns is vital to inform preventive efforts.

methodsWe conducted a prospective cohort study, 12 October 2018 to 31 October 2019 to describe the association of maternal and environmental GN colonization with bloodstream infection (BSI) among neonates admitted to a neonatal intensive care unit (NICU) in Western India. We assessed rectal and vaginal colonization in pregnant women presenting for delivery and colonization in neonates and the environment using culture-based methods. We also collected data on BSI for all NICU patients, including neonates born to unenrolled mothers. Organism identification, antibiotic susceptibility testing, and next-generation sequencing (NGS) were performed to compare BSI and related colonization isolates.

resultsAmong 952 enrolled women who delivered, 257 neonates required NICU admission, and 24 (9.3%) developed BSI. Among mothers of neonates with GN BSI (n = 21), 10 (47.7%) had rectal, 5 (23.8%) had vaginal, and 10 (47.7%) had no colonization with resistant GN organisms. No maternal isolates matched the species and resistance pattern of associated neonatal BSI isolates. Thirty GN BSI were observed among neonates born to unenrolled mothers. Among 37 of 51 BSI with available NGS data, 21 (57%) showed a single nucleotide polymorphism distance of ≤5 to another BSI isolate.

conclusionsProspective assessment of maternal GN colonization did not demonstrate linkage to neonatal BSI. Organism-relatedness among neonates with BSI suggests nosocomial spread, highlighting the importance of NICU infection prevention and control practices to reduce GN BSI.

Indexed as

Anti-Infective AgentsCommunicable DiseasesCross InfectionSepsisFemaleHumansInfant, NewbornIntensive Care Units, NeonatalPharmaceutical PreparationsPregnancyProspective StudiesAnti-Infective AgentsPharmaceutical Preparationsantimicrobial resistancenewbornsepsis

Identifiers

PMID37406039
PMCPMC10321698
OpenAlexW4383199099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.